Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
programme. About the CoSTAR National Lab : The CoSTAR National Lab is the largest ever investment in creative industries R&D by UKRI. A £51.1m programme led by Royal Holloway, University of London to develop
-
assist with the delivery of teaching across the programme and will have the opportunity to co-lead a module. You will also assist with assessment and student support duties. The post holder will be
-
About the Role We are looking to appoint a Research Operations Manager for the Metabolic Health Research Group, led by Professor William Alazawi. The group has a thriving programme of translational
-
About the Role We are looking for a teaching fellow to undertake a one-year post in the school, to support the delivery of our taught postgraduate programme in Engineering Management. About You We
-
Waltham Forest. The Weight Action Programme is commissioned by Tower Hamlets. About Queen Mary At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously
-
this Fellowship. The Fellowship will be for a period up to 6 months (normally between January and June 2026), based in Paris or London, or split between the two cities. As a Fellow, you will develop a programme of
-
points throughout the flexible programme. You will work within a team of Student Experience and Programme Delivery Managers and be supported by a team of Programme Administrators, in assisting
-
CoSector CoSector – University of London is a digital services provider that operates as part of the University of London. It evolved from the University of London Computer Centre (ULCC), established in 1968
-
to degree level or equivalent and have experience of managing teaching and learning activities or similar within Higher Education. You will have experience of managing teaching activities and programme
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing